BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 23123127)

  • 1. Evaluation of immunohistochemical markers of lymphatic and blood vessels in canine mammary tumours.
    Sleeckx N; Van Brantegem L; Fransen E; Van den Eynden G; Casteleyn C; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2013 May; 148(4):307-17. PubMed ID: 23123127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphangiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):184-93. PubMed ID: 24225342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis in canine mammary tumours: a morphometric and prognostic study.
    Sleeckx N; Van Brantegem L; Van den Eynden G; Fransen E; Casteleyn C; Van Cruchten S; Veldhuis Kroeze E; Van Ginneken C
    J Comp Pathol; 2014; 150(2-3):175-83. PubMed ID: 24231306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of vascular endothelial growth factor in canine mammary tumours.
    Santos AA; Oliveira JT; Lopes CC; Amorim IF; Vicente CM; Gärtner FR; Matos AJ
    J Comp Pathol; 2010 Nov; 143(4):268-75. PubMed ID: 20570280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.
    Castro EC; Galambos C
    Pediatr Dev Pathol; 2009; 12(3):187-94. PubMed ID: 18937526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: a survival study.
    Santos A; Lopes C; Frias C; Amorim I; Vicente C; Gärtner F; Matos Ad
    Vet J; 2011 Dec; 190(3):396-402. PubMed ID: 21269852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer.
    Clemente M; Pérez-Alenza MD; Illera JC; Peña L
    Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of lymphatic vessels in human dental pulp: a morphological study.
    Gerli R; Secciani I; Sozio F; Rossi A; Weber E; Lorenzini G
    Eur J Oral Sci; 2010 Apr; 118(2):110-7. PubMed ID: 20486999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic value of c-met in canine mammary tumours.
    Chen YC; Chen YY; Liao JW; Chang SC
    Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p63: a novel myoepithelial cell marker in canine mammary tissues.
    Gama A; Alves A; Gartner F; Schmitt F
    Vet Pathol; 2003 Jul; 40(4):412-20. PubMed ID: 12824513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucin 6 and Tn antigen expression in canine mammary tumours: correlation with pathological features.
    Tavares C; de Oliveira JT; Lopes C; Carvalheira J; Matos AJ; Rutteman G; Reis CA; Gärtner F
    J Comp Pathol; 2012 Nov; 147(4):410-8. PubMed ID: 22595635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Canine invasive lobular carcinoma of the mammary gland: morphological and immunohistochemical characterizations of three cases.
    Ressel L; Millanta F; Poli A
    J Comp Pathol; 2011 May; 144(4):303-7. PubMed ID: 20961557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers.
    Kim NH; Lim HY; Im KS; Kim JH; Sur JH
    J Comp Pathol; 2013 May; 148(4):298-306. PubMed ID: 23079102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evidence of the presence of lymphatic vessels immunoreactive for D2-40 and Prox-1 in human pterygium.
    Cimpean AM; Poenaru Sava M; Raica M; Ribatti D
    Oncol Rep; 2011 Nov; 26(5):1111-3. PubMed ID: 21667034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
    Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
    Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue.
    Amorim I; Lopes CC; Faustino AM; Pereira PD
    J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canine mammary carcinomas: influence of histological grade, vascular invasion, proliferation, microvessel density and VEGFR2 expression on lymph node status and survival time.
    Diessler ME; Castellano MC; Portiansky EL; Burns S; Idiart JR
    Vet Comp Oncol; 2017 Jun; 15(2):450-461. PubMed ID: 26833549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of 14-3-3 σ protein in normal and neoplastic canine mammary gland.
    Suárez-Bonnet A; Herráez P; Martín de las Mulas J; Rodríguez F; Déniz JM; Espinosa de los Monteros A
    Vet J; 2011 Dec; 190(3):345-51. PubMed ID: 21251859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.
    Van der Auwera I; Van den Eynden GG; Colpaert CG; Van Laere SJ; van Dam P; Van Marck EA; Dirix LY; Vermeulen PB
    Clin Cancer Res; 2005 Nov; 11(21):7637-42. PubMed ID: 16278382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical and molecular analysis of caveolin-1 expression in canine mammary tumors.
    Zuccari DA; Castro R; Gavioli AF; Mancini UM; Frade CS; Leonel C
    Genet Mol Res; 2012 Jan; 11(1):153-65. PubMed ID: 22370882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.